Interferon gamma-dependent transactivation of epidermal growth factor receptor. 2007

Elena Burova, and Konstantin Vassilenko, and Victoria Dorosh, and Ilya Gonchar, and Nikolai Nikolsky
Department of Intracellular Signaling and Transport, Institute of Cytology of Russian Academy of Sciences, St.-Petersburg 194064, Russia. lenbur87@mail.ru

The present report provides evidence that, in A431 cells, interferon gamma (IFNgamma) induces the rapid (within 5 min), and reversible, tyrosine phosphorylation of the epidermal growth factor receptor (EGFR). IFNgamma-induced EGFR transactivation requires EGFR kinase activity, as well as activity of the Src-family tyrosine kinases and JAK2. Here, we show that IFNgamma-induced STAT1 activation in A431 and HeLa cells partially depends on the kinase activity of both EGFR and Src. Furthermore, in these cells, EGFR kinase activity is essential for IFNgamma-induced ERK1,2 activation. This study is the first to demonstrate that EGFR is implicated in IFNgamma-dependent signaling pathways.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015533 Transcriptional Activation Processes that stimulate the GENETIC TRANSCRIPTION of a gene or set of genes. Gene Activation,Genetic Induction,Transactivation,Induction, Genetic,Trans-Activation, Genetic,Transcription Activation,Activation, Gene,Activation, Transcription,Activation, Transcriptional,Genetic Trans-Activation,Trans Activation, Genetic
D047428 Protein Kinase Inhibitors Agents that inhibit PROTEIN KINASES. Protein Kinase Inhibitor,Inhibitor, Protein Kinase,Inhibitors, Protein Kinase,Kinase Inhibitor, Protein,Kinase Inhibitors, Protein
D048052 Mitogen-Activated Protein Kinase 3 A 44-kDa extracellular signal-regulated MAP kinase that may play a role the initiation and regulation of MEIOSIS; MITOSIS; and postmitotic functions in differentiated cells. It phosphorylates a number of TRANSCRIPTION FACTORS; and MICROTUBULE-ASSOCIATED PROTEINS. Extracellular Signal-Regulated Kinase 1,ERK1 Kinase,MAPK3 Mitogen-Activated Protein Kinase,Meiosis-Activated Myelin Basic Protein Kinase p44(mpk),Microtubule-Associated Protein-2 Kinase,PSTkinase p44mpk,Protein-Serine-Threonine Kinase p44(mpk),p44 MAPK,Extracellular Signal Regulated Kinase 1,Kinase, ERK1,Kinase, Microtubule-Associated Protein-2,MAPK3 Mitogen Activated Protein Kinase,Microtubule Associated Protein 2 Kinase,Mitogen Activated Protein Kinase 3,p44mpk, PSTkinase
D050794 STAT1 Transcription Factor A signal transducer and activator of transcription that mediates cellular responses to INTERFERONS. Stat1 interacts with P53 TUMOR SUPPRESSOR PROTEIN and regulates expression of GENES involved in growth control and APOPTOSIS. Gamma-Activated Factor, 91 kDa,STAT-91 Protein,STAT-91 Transcription Factor,STAT1 Protein,STAT91 Transcription Factor,Signal Transducer and Activator of Transcription 1,Transcription Factor STAT91,Gamma Activated Factor, 91 kDa,STAT 91 Protein,STAT 91 Transcription Factor,Transcription Factor, STAT-91,Transcription Factor, STAT1,Transcription Factor, STAT91

Related Publications

Elena Burova, and Konstantin Vassilenko, and Victoria Dorosh, and Ilya Gonchar, and Nikolai Nikolsky
May 2000, IUBMB life,
Elena Burova, and Konstantin Vassilenko, and Victoria Dorosh, and Ilya Gonchar, and Nikolai Nikolsky
September 2001, The Journal of biological chemistry,
Elena Burova, and Konstantin Vassilenko, and Victoria Dorosh, and Ilya Gonchar, and Nikolai Nikolsky
March 2012, British journal of pharmacology,
Elena Burova, and Konstantin Vassilenko, and Victoria Dorosh, and Ilya Gonchar, and Nikolai Nikolsky
January 2006, Methods in molecular biology (Clifton, N.J.),
Elena Burova, and Konstantin Vassilenko, and Victoria Dorosh, and Ilya Gonchar, and Nikolai Nikolsky
January 2004, Inflammopharmacology,
Elena Burova, and Konstantin Vassilenko, and Victoria Dorosh, and Ilya Gonchar, and Nikolai Nikolsky
November 2006, Molecular endocrinology (Baltimore, Md.),
Elena Burova, and Konstantin Vassilenko, and Victoria Dorosh, and Ilya Gonchar, and Nikolai Nikolsky
January 2004, The Journal of biological chemistry,
Elena Burova, and Konstantin Vassilenko, and Victoria Dorosh, and Ilya Gonchar, and Nikolai Nikolsky
October 2001, Molecular and cellular biology,
Elena Burova, and Konstantin Vassilenko, and Victoria Dorosh, and Ilya Gonchar, and Nikolai Nikolsky
March 1996, Experimental cell research,
Elena Burova, and Konstantin Vassilenko, and Victoria Dorosh, and Ilya Gonchar, and Nikolai Nikolsky
December 2014, Journal of cellular physiology,
Copied contents to your clipboard!